Nanogrow Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

Nanogrow General Information

Description

Developer of biological treatments designed to create safer and targeted therapies. The company provides research and development of single-domain antibodies for use in targeted treatments, pre-clinical studies to validate therapeutic applications, and advancements in delivery methods such as topical, inhalation, injectable, and oral administration, enabling clients and users to access novel therapies tailored to specific medical conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Montevideo
  • Uruguay
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Vertical(s)
Corporate Office
  • Montevideo
  • Uruguay

Nanogrow Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanogrow Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 22-Nov-2024 Completed Generating Revenue
3. Seed Round 01-Mar-2024 Completed Generating Revenue
2. Accelerator/Incubator 24-Feb-2023 $200K Completed Generating Revenue
1. Accelerator/Incubator 15-Feb-2021 $200K $200K Completed Generating Revenue
To view Nanogrow’s complete valuation and funding history, request access »

Nanogrow Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanogrow Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Richi Entrepreneurs Accelerator/Incubator
ATGen Global Corporation Minority
Centro de Innovación y Emprendimientos Accelerator/Incubator
Grid Exponential Accelerator/Incubator Minority
To view Nanogrow’s complete investors history, request access »

Nanogrow FAQs

  • When was Nanogrow founded?

    Nanogrow was founded in 2020.

  • Where is Nanogrow headquartered?

    Nanogrow is headquartered in Montevideo, Uruguay.

  • What is the size of Nanogrow?

    Nanogrow has 19 total employees.

  • What industry is Nanogrow in?

    Nanogrow’s primary industry is Drug Discovery.

  • Is Nanogrow a private or public company?

    Nanogrow is a Private company.

  • What is Nanogrow’s current revenue?

    The current revenue for Nanogrow is .

  • How much funding has Nanogrow raised over time?

    Nanogrow has raised $1.4M.

  • Who are Nanogrow’s investors?

    Richi Entrepreneurs, ATGen Global, Centro de Innovación y Emprendimientos, and Grid Exponential have invested in Nanogrow.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process